TY - JOUR
T1 - Factors associated with health-related quality-of-life in breast cancer survivors
T2 - Influence of the type of surgery
AU - Ohsumi, Shozo
AU - Shimozuma, Kojiro
AU - Morita, Satoshi
AU - Hara, Fumikata
AU - Takabatake, Daisuke
AU - Takashima, Seiki
AU - Taira, Naruto
AU - Aogi, Kenjiro
AU - Takashima, Shigemitsu
N1 - Funding Information:
This work was supported by a Grant-in-Aid for research on cancer treatment from the Ministry of Health, Labor, and Welfare of Japan (13-10).
PY - 2009
Y1 - 2009
N2 - Objective: To determine if health-related quality-of-life (QOL) differences existed between breast cancer (BC) survivors receiving mastectomy and those receiving breast-conserving treatment (BCT). Factors associated with QOL in long-term BC survivors were also identified. Methods: One hundred patients who had previously undergone BC surgery and were alive without recurrence for >5 years were asked to answer the patient-administered questionnaires to assess their QOL (Functional Assessment of Cancer Therapy scale-Breast: FACT-B) and psychological distress (Hospital Anxiety and Depression Scale: HADS). Of them, 93 responded to the questionnaires affirmatively. Results: Although none of the QOL scores were related to the surgical procedures, statistically significant relationships were found between age and the scores of FACT-General and social/family well-being (SWB), and between the educational status and scores of SWB in univariate analyses. There was no statistically significant relationship between psychological distress and each factor examined. In multivariate analyses, significant correlations were established between scores of the FACT-BC subscale (FACT-BCS) and the type of surgery and between those on the FACT SWB subscale and age at study or educational status. Namely, patients who had undergone BCT, younger patients and patients with higher educational background scored higher QOL. Conclusions: Among the BC survivors, those who underwent BCT experienced significantly but slightly better QOL than those who received mastectomy in FACT-BCS assessments. Younger patients and patients with higher educational backgrounds experienced significantly better SWB.
AB - Objective: To determine if health-related quality-of-life (QOL) differences existed between breast cancer (BC) survivors receiving mastectomy and those receiving breast-conserving treatment (BCT). Factors associated with QOL in long-term BC survivors were also identified. Methods: One hundred patients who had previously undergone BC surgery and were alive without recurrence for >5 years were asked to answer the patient-administered questionnaires to assess their QOL (Functional Assessment of Cancer Therapy scale-Breast: FACT-B) and psychological distress (Hospital Anxiety and Depression Scale: HADS). Of them, 93 responded to the questionnaires affirmatively. Results: Although none of the QOL scores were related to the surgical procedures, statistically significant relationships were found between age and the scores of FACT-General and social/family well-being (SWB), and between the educational status and scores of SWB in univariate analyses. There was no statistically significant relationship between psychological distress and each factor examined. In multivariate analyses, significant correlations were established between scores of the FACT-BC subscale (FACT-BCS) and the type of surgery and between those on the FACT SWB subscale and age at study or educational status. Namely, patients who had undergone BCT, younger patients and patients with higher educational background scored higher QOL. Conclusions: Among the BC survivors, those who underwent BCT experienced significantly but slightly better QOL than those who received mastectomy in FACT-BCS assessments. Younger patients and patients with higher educational backgrounds experienced significantly better SWB.
KW - Breast cancer survivor
KW - Breast-conserving treatment
KW - Quality of life
KW - Type of surgery
UR - http://www.scopus.com/inward/record.url?scp=68849096312&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=68849096312&partnerID=8YFLogxK
U2 - 10.1093/jjco/hyp060
DO - 10.1093/jjco/hyp060
M3 - Article
C2 - 19520689
AN - SCOPUS:68849096312
SN - 0368-2811
VL - 39
SP - 491
EP - 496
JO - Japanese journal of clinical oncology
JF - Japanese journal of clinical oncology
IS - 8
ER -